[EN] TARGETED PROTEIN DEGRADATION<br/>[FR] DÉGRADATION CIBLÉE DE PROTÉINES
申请人:C4 THERAPEUTICS INC
公开号:WO2020132561A1
公开(公告)日:2020-06-25
This invention provides pharmaceutical protein degraders and E3 ubiquitin ligase binders for therapeutic applications as described further herein.
这项发明提供了用于治疗应用的药用蛋白质降解剂和E3泛素连接酶结合物。
PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATION
申请人:MacroChem Corporation
公开号:EP1648364A2
公开(公告)日:2006-04-26
Pharmaceutical Compositions for Topical Application
申请人:Chan Thomas
公开号:US20070287688A1
公开(公告)日:2007-12-13
Compounds of Formula I are useful as skin penetration enhancing agents: (I) wherein: R represents a linear, saturated or unsaturated, substituted or unsubstituted hydrocarbyl radical; and X represents a —(CO)O—, —O(CO)—, C═O, CONH, O, NHCONH, S, or S═O radical. Compositions and methods using these compounds are also described.
[EN] PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATION<br/>[FR] COMPOSITIONS PHARMACEUTIQUES POUR APPLICATION TOPIQUE
申请人:MACROCHEM CORP
公开号:WO2005007100A2
公开(公告)日:2005-01-27
Compounds of Formula I are useful as skin penetration enhancing agents: (I) wherein: R represents a linear, saturated or unsaturated, substituted or unsubstituted hydrocarbyl radical; and X represents a -(CO)O-, -O(CO)-, C=O, CONH, O, NHCONH, S, or S=O radical. Compositions and methods using these compounds are also described.